Helping You Build Wealth With Honest Research
Since 1996. Read On...

MEMBER'S LOGINX

     
Invalid Username / Password
   
     
   
     
 
Invalid Captcha
   
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

STRIDES PHARMA SCIENCE Gains 4%; BSE HEALTHCARE Index Up 0.5%
Fri, 27 Sep 14:25

STRIDES PHARMA SCIENCE Gains 4%; BSE HEALTHCARE Index Up 0.5%Image source: Chunumunu/www.istockphoto.com

STRIDES PHARMA SCIENCE share price has zoomed 4% and is presently trading at Rs 1,425.4.

Meanwhile, the BSE HEALTHCARE index is at 44,338.6 (up 0.5%).

Among the top gainers in the BSE HEALTHCARE index today are Natco Pharma (up 2.8%) and Sun Pharma (up 2.4%).

GLAND PHARMA (down 3.6%) and NARAYANA HRUDAYALAYA (down 2.2%) are among the top losers today.

Over the last one year, STRIDES PHARMA SCIENCE has moved up from Rs 535.7 to Rs 1,425.4, registering a gain of Rs 889.7 (up 166.1%).

On the other hand, the BSE HEALTHCARE index has moved up from 27,800.9 to 44,338.6, registering a gain of 59.5% during the last 12 months.

The top gainers among the BSE HEALTHCARE index stocks during this same period were Jubilant Pharmova (up 181.5%), SUVEN PHARMACEUTICALS (up 121.7%) and Glenmark Pharma (up 115.3%).

Must See: These Segments are Witnessing Incredible Growth with Modi's Push

What About the Benchmark Indices?

The BSE Sensex is at 85,614.0 (down 0.3%).

The top losers among the BSE Sensex today are Power Grid Corp. (down 2.9%) and Bharti Airtel (down 2.3%). The most traded stocks in the BSE Sensex are Tata Steel and Tata Motors.

In the meantime, NSE Nifty is at 26,201.9 (down 0.1%). Power Grid Corp. and Bharti Airtel are among the top losers in NSE NIFTY.

Over the last 12 months, the BSE Sensex has moved up from 66,023.7 to 85,614.0, registering a gain of 19,590.3 points (up 29.7%).

STRIDES PHARMA SCIENCE Financial Update...

STRIDES PHARMA SCIENCE net profit grew 239.9% YoY to Rs 801 million for the quarter ended June 2024, compared to a profit of Rs 236 million a year ago. Net sales rose 16.9% to Rs 10,875 million during the period as against Rs 9,300 million in April-June 2023.

For the year ended March 2024, STRIDES PHARMA SCIENCE reported 35.7% increase in net profit to Rs -1,485 million compared to net loss of Rs 2,309 million during FY23. Revenue of the company grew 9.8% to Rs 40,511 million during FY24.

The current Price to earnings ratio of STRIDES PHARMA SCIENCE, based on rolling 12 month earnings, stands at 156.5.


Equitymaster requests your view! Post a comment on "STRIDES PHARMA SCIENCE Gains 4%; BSE HEALTHCARE Index Up 0.5%". Click here!